An Update: Covid-19 vaccine developments in India

India's Serum institute is ready with 40 million doses of AstraZeneca's Vaccine ready to ship and the Novavax's vaccine will be made. The bulk of Novavax vaccine has been received by Serum. Both of these need regulatory approval.

Serum has been working on getting regulatory approval for AstraZeneca's vaccine  from India based on its trial on 1600 participants. 

The final recipients of these vaccines are yet to be published.

• Additionally, India has two home-grown vaccines in development..

• Reddy's laboratories is carrying put out a trial of Russia's Sputnik vaccine developed by the Gemaleya Institute.

• Other major development has been the over 90% success rate of the vaccine developed by Pfizer and BioNTech.

Current (as of 11/14/2020) statistics for the most affected 3 countries derived from Johns Hopkins' data is shown below.

Country	All Time		Past Day		Past Week		Past Month
	Confirmed Cases	Deaths	New Cases	New Deaths	New Cases	New Deaths	New Cases	New Deaths
INDIA	8,773,479	129,188	44,684	520	311,399	3,626	1,466,382	17,922
BRAZIL	5,810,652	164,737	29,070	456	179,471	2,722	669.789	12,990
US	10,737,335	244,332	177,224	1,138	979,723	7,327	2,841,426	27,143

Source :    https://coronavirus.jhu.edu/region

It goes beyond saying that we need to outpace the virus and develop the vaccine(s) to put an end to this  human tragedy.